NeuroSense Therapeutics Q1 EPS $(0.33) Down From $(0.24) YoY
Portfolio Pulse from Happy Mohamed
NeuroSense Therapeutics reported Q1 losses of $(0.33) per share, a 37.5% decrease from $(0.24) per share YoY.
June 01, 2023 | 12:50 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NeuroSense Therapeutics' Q1 earnings show a 37.5% YoY decrease in losses, reporting $(0.33) per share.
NeuroSense Therapeutics reported a significant increase in losses YoY, which may negatively impact investor sentiment and lead to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100